MARCH 8, 2024
Biophytis presented the potential of Ruvembri™ in the treatment of Duchenne Muscular Dystrophy Biophytis presented the results of its recent clinical trials with Ruvembri™ at
Biophytis presented the potential of Ruvembri™ in the treatment of Duchenne Muscular Dystrophy Biophytis presented the results of its recent clinical trials with Ruvembri™ at
“Live healthier longer” – Publication of a book on the medicine and science of longevity Biophytis announces the publication of a book written by Stanislas
Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet Biophytis announces the publication of an